mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
2e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-06 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
3e-06 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.27 |
3e-06 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-06 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
4e-06 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
4e-06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-06 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
5e-06 |